Physician

Mohammad Hammad Rashid, MD

According to 2025 Medicare claims, Mohammad Rashid, MD (NPI: 1477545655) practices medical oncology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is TOLEDO CLINIC INCORPORATED (NPI: 1144217894; TIN: 340936207) and primary practice location at 43623-3536. Rashid is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Rashid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 493 traditional Medicare patients, billed 105,872 HCPCS/CPT codes, and received $1,919,587 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,113 prescription claims across 215 beneficiaries totaling $2,895,661 in drug costs, led by Revlimid (Lenalidomide). DME data shows 41 claims. Open Payments data shows 7 records totaling $255. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $45,345 to $1,919,587. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $433,609 to $2,895,661. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,399 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$960K$1.9M2015 Medicare payment: $45,345 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $57,723 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $57,476 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $139,462 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $857,225 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,358,987 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,599,203 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,562,591 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,639,359 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,919,587 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015192852$45,345
20162201,064$57,723
20172201,019$57,476
20182558,229$139,462
201951770,788$857,225
2020552102,323$1,358,987
2021550114,525$1,599,203
2022559120,962$1,562,591
202347594,470$1,639,359
2024493105,872$1,919,587

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.9M2015 Drug cost: $433,609 (USD; Tot_Drug_Cst)2016 Drug cost: $505,277 (USD; Tot_Drug_Cst)2017 Drug cost: $953,062 (USD; Tot_Drug_Cst)2018 Drug cost: $654,441 (USD; Tot_Drug_Cst)2019 Drug cost: $473,223 (USD; Tot_Drug_Cst)2020 Drug cost: $1,987,651 (USD; Tot_Drug_Cst)2021 Drug cost: $1,891,553 (USD; Tot_Drug_Cst)2022 Drug cost: $2,168,393 (USD; Tot_Drug_Cst)2023 Drug cost: $2,321,466 (USD; Tot_Drug_Cst)2024 Drug cost: $2,895,661 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201593565$433,609
2016106615$505,277
2017109713$953,062
201890532$654,441
2019133561$473,223
20201961,015$1,987,651
20212321,188$1,891,553
20222051,157$2,168,393
20232251,091$2,321,466
20242151,113$2,895,661

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.6K$7.3K2015 Medicare payment: $7,281 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $6,115 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $968 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $965 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,951 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $596 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $945 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $601 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151166$7,281
2016N/R73$6,115
2017N/R16$968
2018N/R12$965
2019N/R23$4,951
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R12$596
2023N/R32$945
2024N/R41$601

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more93174$133
96413Administration of chemotherapy into vein, 1 hour or less72175$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more234459$86
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less80126$44
96372Injection of drug or substance under skin or into muscle69129$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide23609$400,150
LumakrasSotorasib17510$361,645
TasignaNilotinib Hcl16448$328,407
LenalidomideLenalidomide27686$316,765
NubeqaDarolutamide16480$194,160

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R17$358
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R13$201
J8520Capecitabine, oral, 150 mgNN/R11$43

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$255Pinnacle Biologics, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mohammad Hammad Rashid, MD?

Tedicare shows public-source Medicare data for Mohammad Hammad Rashid, MD (NPI 1477545655), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammad Hammad Rashid, MD have ACO affiliation data?

Mohammad Hammad Rashid, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Mohammad Hammad Rashid, MD?

Mohammad Hammad Rashid, MD is linked to TOLEDO CLINIC INCORPORATED (billing NPI 1144217894) in the available physician profile data.

Does Mohammad Hammad Rashid, MD have Open Payments data?

Mohammad Hammad Rashid, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.